CAPTRUST Financial Advisors
LJPC

CAPTRUST Financial Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,600
Closed -$12K – 5398
2021
Q4 		$12K Buy
+2,600
New +$10.8K ﹤0.01% 3638
2021
Q2 		– Sell
-2,600
Closed -$11K – 4873
2021
Q1 		$11K Buy
+2,600
New +$14.3K ﹤0.01% 3414

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAPTRUST Financial Advisors's LJPC Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2022, closing a stake of 2,600 shares — an estimated $12K sold.

CAPTRUST Financial Advisors first reported a position in LJPC in Q1 2021 and held it in 2 quarters. The position peaked at $12K in Q4 2021. 45 funds tracked by Wall St. Rank hold LJPC as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,600 La Jolla Pharmaceutical Company shares in Q1 2022, an estimated $12K.
  • CAPTRUST Financial Advisors first reported a position in La Jolla Pharmaceutical Company in Q1 2021 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's La Jolla Pharmaceutical Company position peaked at $12K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.